Elbe Valley Medical Ltd

Société |

A propos de votre organisation

We are a private reseach company based in Ireland and we are focused on several areas but cybernetics is on main area. We are developing a solution for treating large and agressive cancer tumours very quickly using our microbots.

Our solution is based on the premise that a tumour starved of blood supply will die. It is a proprietary blood-borne nanorobot system. Using our system, a patient will be injected with over a billion of our tiny devices. These devices will travel all around the body via the bloodstream and when activated, they will stop blood flow at the blood capillary level thus choking the tumour in the target area in mere minutes. Our system is more suitable for large and aggressive tumours. In fact the more severe cancers are easier to treat than smaller tumours. While we are currently focused on beating cancer, our technology has many applications outside the field of Oncology.

http://elbevalley.com

Actualités

Rob Reynolds (Executive Chairman, Elbe Valley Medical Ltd )

Publié il y a 3 ans

Virtual Merger Announcement

Elbe Valley Medical is Virtually Merging with The Optimal Outcome Ecosystem.

An LOI for up to $10M (USD) has been signed with Optimal Outcome Solutions for Breakthrough Cancer Treatment on completion of their Virtual Merger

Illustration of microbots blocking capillaries of humans and animals and destroying the tumour.

· Virtual Merger provides access to a fully developed business ecosystem to support our ambitious growth plans

· Up to $10Million funding round and additional resources to facilitate pioneering research and development on completion of their Virtual Merger

· Funds to be spent on product development to enable commercialisation.

Mullingar, Ireland: Elbe Valley Medical, a privately held company that is developing a breakthrough treatment using microbots to destroy damaged or unwanted tissue such as Cancer in animals and humans, today announced the successful instantiation of a virtual merger with Optimal Outcome Solutions via its Ecosystem of Affiliates in the United States and will receive up to $10Million in funding subject to completion of the virtual merger. The company plans to use the new liquidity and resources; to further invest in pioneering research and development, accelerate international growth and commercialisation in the veterinary market in 2020.

“We are extremely pleased to be making this announcement today and to affiliate with Optimal. Their support enables us to bring our nanotechnology platform into the veterinary space firstly and later to the clinic. Our technology aims to vastly reduce the cost of cancer care, whilst delivering better outcomes for our patients. This virtual merger was an excellent choice for us as a young company, as we gain access to a fully developed business ecosystem to support and enable our ambitious growth plans.” said Robert Reynolds, Founder and Executive Chairman of Elbe Valley Medical.

Bob Reno

Executive Chairman

Optimal Outcome Solutions

“Optimal Outcome Solutions, its Ecosystem of Affiliates and the Optimal Outcome Fund look forward to collaborating with Elbe Valley Medical on completion of their Virtual Merger to bring advancements to cancer treatment which promise a more optimal outcome for all touched by cancer. We expect Elbe Valley Medical to be a cornerstone of innovation within our strategy in healthcare.”

The World Health Organisation predicts that new cancer cases will rise from 18.1 million in 2018 to 29.5 million by 2040. Elbe Valley Medical believes that its micro-robot technology will become the logical choice for healthcare providers entrusted with providing late-stage therapy to cancer sufferers worldwide.

About Elbe Valley Medical

Elbe Valley Medical Limited is a privately funded research company dedicated to developing novel treatments for medical conditions using pioneering microbot technology.

The company was founded in 2017 and is named after the Elbe Valley river in Dresden, Germany where its founder Robert Reynolds invented the proprietary method to treat late stage cancer tumours with microbots.

For more about Optimal Outcome Solutions: https://optimaloutcome.solutions/